Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis

被引:29
|
作者
Vollenberg, Richard [1 ]
Tepasse, Phil-Robin [1 ]
Ochs, Kevin [1 ]
Floer, Martin [2 ]
Strauss, Markus [3 ]
Rennebaum, Florian [1 ]
Kabar, Iyad [1 ]
Rovas, Alexandros [4 ]
Nowacki, Tobias [1 ,5 ]
机构
[1] Univ Hosp Muenster, Dept Med B Gastroenterol Hepatol Endocrinol & Cli, D-48149 Munster, Germany
[2] Klinikum Ibbenburen, Dept Med 1, D-49477 Ibbenburen, Germany
[3] Univ Hosp Muenster, Dept Cardiol Coronary I Peripheral Vasc Dis Heart, D-48149 Munster, Germany
[4] Univ Hosp Muenster, Dept Med D, Div Gen Internal & Emergency Med Nephrol & Rheuma, D-48149 Munster, Germany
[5] Marienhosp Steinfurt, Dept Med Gastroenterol, D-48565 Steinfurt, Germany
来源
VIRUSES-BASEL | 2021年 / 13卷 / 11期
关键词
SARS-CoV-2; COVID-19; syndecan-1; glycocalyx; long-COVID-19; INFECTION;
D O I
10.3390/v13112324
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The COVID-19 pandemic is caused by the SARS CoV-2 virus and can lead to severe lung damage and hyperinflammation. In the context of COVID-19 infection, inflammation-induced degradation of the glycocalyx layer in endothelial cells has been demonstrated. Syndecan-1 (SDC-1) is an established parameter for measuring glycocalyx injury. This prospective, multicenter, observational, cross-sectional study analyzed SDC-1 levels in 24 convalescent patients that had been infected with SARS-CoV-2 with mild disease course without need of hospitalization. We included 13 age-matched healthy individuals and 10 age-matched hospitalized COVID-19 patients with acute mild disease course as controls. In convalescent COVID-19 patients, significantly elevated SDC-1 levels were detected after a median of 88 days after symptom onset compared to healthy controls, whereas no difference was found when compared to SDC-1 levels of hospitalized patients undergoing acute disease. This study is the first to demonstrate signs of endothelial damage in non-pre-diseased, convalescent COVID-19 patients after mild disease progression without hospitalization. The data are consistent with studies showing evidence of persistent endothelial damage after severe or critical disease progression. Further work to investigate endothelial damage in convalescent COVID-19 patients should follow.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Endothelial glycocalyx damage in patients with severe COVID-19 on mechanical ventilation - A prospective observational pilot study
    Astapenko, David
    Tomasova, Adela
    Ticha, Alena
    Hyspler, Radomir
    Chua, Huey Shin
    Manzoor, Mubashar
    Skulec, Roman
    Lehmann, Christian
    Hahn, Robert G.
    Malbrain, Manu L. N. G.
    Cerny, Vladimir
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2022, 81 (03) : 205 - 219
  • [2] Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
    Tepasse, Phil-Robin
    Vollenberg, Richard
    Fobker, Manfred
    Kabar, Iyad
    Schmidt, Hartmut
    Meier, Jorn Arne
    Nowacki, Tobias
    Husing-Kabar, Anna
    NUTRIENTS, 2021, 13 (07)
  • [3] Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study
    Destremau, Marjolaine
    Chaussade, Helene
    Hemar, Victor
    Beguet, Mathilde
    Bellecave, Pantxika
    Blanchard, Elodie
    Barret, Amaury
    Laboure, Gaelle
    Vasco-Moynet, Claire
    Lacassin, Flore
    Morisse, Eloise
    Aguilar, Claire
    Lafarge, Xavier
    Lafon, Marie-Edith
    Bonnet, Fabrice
    Issa, Nahema
    Camou, Fabrice
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (04)
  • [4] Predictive value of coagulation variables and glycocalyx shedding in hospitalized COVID-19 patients - a prospective observational study
    Thaler, Sarah
    Stoehr, Dana
    Kammerer, Tobias
    Nitschke, Tobias
    Hoechter, Dominik J.
    Brandes, Florian
    Mueller, Martin
    Groene, Philipp
    Schaefer, Simon T.
    ACTA CLINICA BELGICA, 2023, 78 (05) : 392 - 400
  • [5] Vascular Endothelial Glycocalyx Damage in COVID-19
    Yamaoka-Tojo, Minako
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 22
  • [6] Delirium in hospitalized COVID-19 patients: a prospective, multicenter, cohort study
    Zhu, Wei
    Bai, Yangjing
    Li, Simin
    Zhang, Meng
    Chen, Jian
    Xie, Peishan
    Bai, Xuejiao
    Zhou, Dong
    Jiang, Yan
    JOURNAL OF NEUROLOGY, 2023, 270 (10) : 4608 - 4616
  • [7] Delirium in hospitalized COVID-19 patients: a prospective, multicenter, cohort study
    Wei Zhu
    Yangjing Bai
    Simin Li
    Meng Zhang
    Jian Chen
    Peishan Xie
    Xuejiao Bai
    Dong Zhou
    Yan Jiang
    Journal of Neurology, 2023, 270 : 4608 - 4616
  • [8] A Multicenter, Prospective, Observational, Cohort-Controlled Study of Clinical Outcomes Following Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Therapy in Hospitalized Patients With COVID-19
    Chauhan, Lakshmi
    Pattee, Jack
    Ford, Joshay
    Thomas, Chris
    Lesteberg, Kelsey
    Richards, Eric
    Bernas, Carl A.
    Loi, Michele
    Dumont, Larry
    Annen, Kyle
    Berg, Mary
    Zirbes, Mercedes
    Knight, Vijaya
    Miller, Amanda
    Jenkins, Timothy C.
    Bennett, Tellen D.
    Monkowski, Daniel
    Boxer, Rebecca S.
    Beckham, J. David
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E466 - E472
  • [9] Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study
    Stefan Hatzl
    Florian Posch
    Nazanin Sareban
    Martin Stradner
    Konrad Rosskopf
    Alexander C. Reisinger
    Philipp Eller
    Michael Schörghuber
    Wolfgang Toller
    Zdenka Sloup
    Florian Prüller
    Katharina Gütl
    Stefan Pilz
    Alexander R. Rosenkranz
    Hildegard T. Greinix
    Robert Krause
    Peter Schlenke
    Gernot Schilcher
    Annals of Intensive Care, 11
  • [10] Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study
    Hatzl, Stefan
    Posch, Florian
    Sareban, Nazanin
    Stradner, Martin
    Rosskopf, Konrad
    Reisinger, Alexander C.
    Eller, Philipp
    Schoerghuber, Michael
    Toller, Wolfgang
    Sloup, Zdenka
    Prueller, Florian
    Guetl, Katharina
    Pilz, Stefan
    Rosenkranz, Alexander R.
    Greinix, Hildegard T.
    Krause, Robert
    Schlenke, Peter
    Schilcher, Gernot
    ANNALS OF INTENSIVE CARE, 2021, 11 (01)